MedTrace Logo

Evaluation of the Clinical and Biological Consequences of Levothyrox® Formula Modification

NCT03569800 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2019-06-20

No results posted yet for this study

Summary

The purpose of this study is to determine whether the recent excipient modification of Levothyrox® in France for a bioequivalent formula has clinical and biological consequence for the patients. The investigators also plan to describe the patient journey in terms of levothyroxine based drugs since this formula modification of Levothyrox®.

Conditions

  • Thyroid Disorder

Interventions

OTHER

self completed questionnaire

self completed questionnaire

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • lionel Groussin, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-11
Primary Completion
2018-11-30
Completion
2019-04-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03569800 on ClinicalTrials.gov